You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 253 No. 24, June 28, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  BRIEF REPORT
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (37)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Atypical Metastasis From Prostate Cancer

Clinical Utility of the Immunoperoxidase Technique for Prostate-Specific Antigen

MAJ Daniel T. Tell, MC; CPT Joseph M. Khoury, MC; COL H. Grant Taylor, MC; MAJ Sparks P. Veasey, MC

JAMA. 1985;253(24):3574-3575.


Abstract

We review our experience with the immunoperoxidase technique of staining tissue for prostate-specific antigen in four patients with atypical metastases from prostate cancer. Our results indicate that this test is clinically useful for the diagnosis of metastatic prostate cancer in patients with an unsuspected primary prostate malignancy. Further, application of prostatic-specific antigen testing may confirm metastatic prostate cancer in atypical sites in patients with a previously diagnosed prostate malignancy.

(JAMA 1985;253:3574-3575)



Author Affiliations

USA; USA; USA; USA

From the Hematology-Oncology Service, Department of Medicine (Drs Tell and Taylor), the Urology Service, Department of Surgery (Dr Khoury), and the Department of Pathology (Dr Veasey), Walter Reed Army Medical Center, Washington, DC.


Footnotes

The opinions or assertions herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.

Reprint requests to the Hematology-Oncology Service, Walter Reed Army Medical Center, 6900 Georgia Ave, Washington, DC 20307-5001 (Dr Taylor).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Unknown primary tumours
Hillen
Postgrad. Med. J. 2000;76:690-693.
ABSTRACT | FULL TEXT  

Treatment of Patients with Cancer of an Unknown Primary Site
Hainsworth and Greco
NEJM 1993;329:257-263.
FULL TEXT  

Tumors of Unknown Origin in the Bone Marrow
Ringenberg et al.
Arch Intern Med 1986;146:2027-2028.
ABSTRACT  

The Undifferentiated Malignant Neoplasm: Identification of Lymphoma Arising in Skeletal Muscle by Immunohistochemical Analysis
Berg et al.
JAMA 1985;254:2625-2626.
ABSTRACT  

Immunoperoxidase in Fine-Needle Aspirate Specimens
Reifler
JAMA 1985;254:2553-2553.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.